News

Biological Derived Devices Market 2022-2029

Market Overview

Pune, India, 11 May 2022: The global biological derived devices market size is expected to witness an elevated growth owing to rising technological advancements and rising demand for stem cell treatments. This information is provided by Fortune Business Insights™, in its report, titled, “Biological Derived Devices Market, 2022-2029.” Also, rising demand for synthetic cells and synthetic genes will boost the growth of the market during the forecast period.

COVID-19 Impact

Pandemic to Cause Setbacks Due to Disruptions in Supply Chains

The COVID-19 pandemic has affected various business sectors across the world and the sector of biologically derived devices is no different. Various corporations are struggling to maintain a stable operation by achieving optimal functionality within a restricted budget. During the peak of the pandemic, the overall health of the workers was given priority. Strict government guidelines enforced movement restrictions on the general population which led to lessened production measures. Disruptions in supply chains will further deteriorate the state of the market during the forecast period.

Segments

On the basis of application, the market can be divided into regenerative medicine, diabetes, neurology, oncology, orthopedics, and others.

By end-user, the market can be broken down into hospitals, specialty clinics, and others.

In terms of region, the market can be categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Report Coverage

The report contains a thorough study of the segments and subsegments along with a comprehensive analysis of the market overview. Also, the report provides additional insights by integrating factors such as drivers, restraints, opportunities, and ongoing trends. It further packs an exclusive examination of the global overview by incorporating the factors that shape the overall market. The COVID-19 impacts have been mentioned and presented in the report. A section of the report has been dedicated towards declaring various strategies that accompany the dominant players.

Drivers & Restraints

Rising Demand from the Pharmaceutical Sector to Bolster Growth

Technologically advancements have led to rising demand for therapeutic solutions such as replacement of cartilage, bone growth stimulators and biopharmaceuticals will increase the biological derived devices market share. Also, declining costs of DNA synthesizing and sequencing and increasing funds for research & development activities will fuel the growth of the market. Additionally, incremental development in synthetic biology and rising investments from the private sector will increase the adoption of products in the market.

However, a higher cost associated with these costs will limit the growth of the market during the forecast period.

Regional Insights

Technological Advancements to Push a Larger Market Share in North America

North America will hold the largest market share during the forecast period due to increasing technological advancements and rising government initiatives. Also, a large presence of key market players will boost the biological derived devices market growth.

Europe will contribute a considerable market share due to increased funding towards research and development activities by the government. Increasing affordability and constantly developing healthcare infrastructure by emerging economies such as India and China will help Asia Pacific project a substantial market share.

Competitive Landscape

Mergers & Acquisitions to Ramp up the Competition in Terms of Gaining Value

The global portfolio for the market is comprises of various competitive business scenarios where the dominant market players are constantly trying to compete for gaining valuable market share. These strategies include mergers & acquisitions, collaborations, and launching novel products. For example, in November 2019, Takara Bio Inc. launched the world’s first commercially available small intestinal epithelial cells that were derived from human induced pluripotent stem cells. The new Cellartis Intestinal Epithelial Cells (from ChiPSC18) Kit was jointly developed after a method to derive these cells were extracted from hiPSCs.

Industry Development

  • June 2020: Illumina Inc. announced that they are focusing their capabilities towards analyzing and interpret data produced by their own sequencing systems by acquiring BlueBee. BlueBee is a cloud-based software company that can provide genomics analysis solutions for research and clinical applications

List of Key Players Present in the Market

  • Integra LifeSciences Corporation
  • Braun Melsungen AG
  • NuVasive Inc.
  • Osiris Therapeutics Inc.
  • STEMCELL Technologies Inc.
  • Zimmer Biomet Holdings Inc.
  • Celgene Corporation
  • Bioventus LLC
  • BD Diagnostics
  • TERUMO BCT Inc.
  • Thermo Fischer Scientific Inc.

Table Of Content:

Moreover, Introduction

1.1. Moreover, Research Scope

1.2. Moreover, Market Segmentation

1.3. Moreover, Research Methodology

1.4. Moreover, Definitions and Assumptions

Executive Summary

Market Dynamics

3.1. Moreover, Market Drivers

3.2. Moreover, Market Restraints

3.3. Moreover, Market Opportunities

Moreover, Key Insights

4.1. Key Industry Developments – Moreover, Merger, Acquisitions, and Partnerships

4.2. Porter’s Five Forces Moreover, Analysis

4.3. Moreover, SWOT Analysis

4.4. Moreover, Technological Developments

4.5. Moreover, Value Chain Analysis

4.6. Moreover, Impact of COVID-19 on Market

5.Key Findings / Moreover, Summary

5.1 North America Sales, Revenue and Market Share by Country

5.1.1 North America Sales and Market Share by Country (2022-2029)

5.1.2 North America Revenue and Market Share by Country (2022-2029)

5.2 United States Sales and Growth Rate (2022-2029)

5.3 Canada Sales and Growth Rate (2022-2029)

5.4 Mexico Sales and Growth Rate (2022-2029)

8 South America by Country

8.1 South America Sales, Revenue and Market Share by Country

8.1.1 South America Sales and Market Share by Country (2022-2029)

8.1.2 South America Revenue and Market Share by Country (2022-2029)

8.2 Brazil Sales and Growth Rate (2022-2029)

8.3 Argentina Sales and Growth Rate (2022-2029)

8.4 Colombia Sales and Growth Rate (2022-2029)

9 Middle East and Africa by Countries

9.1 Moreover, Middle East and Africa Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Sales and Market Share by Country (2022-2029)

9.1.2 Moreover, Middle East and Africa Revenue and Market Share by Country (2022-2029)

9.2 Saudi Arabia Sales and Growth Rate (2022-2029)

9.3 Moreover, Turkey Sales and Growth Rate (2022-2029)

9.4 Egypt Sales and Growth Rate (2022-2029)

9.5 Moreover, Nigeria Sales and Growth Rate (2022-2029)

10 U.S. Healthcare Assets Management Market In Developing Countries

11 South America Analysis by Countries

12 Moreover, Competitive Landscape

13 Moreover, Industry Outlook

13.1 Moreover, Market Driver Analysis

13.1.2 Moreover, Market Restraints Analysis

13.1.3 Moreover, Market Trends Analysis

13.2 Moreover, Merger, Acquisition and New Investment

13.3 Moreover, News of Product Release

14 Moreover, Global Forecast

15 Moreover, New Project Feasibility Analysis

15.1 Moreover, Industry Barriers and New Entrants SWOT Analysis

15.1.1 Moreover, Porter’s Five Forces Analysis

15.1.2 Moreover, New Entrants SWOT Analysis

15.2 Moreover, Analysis and Suggestions on New Project Investment

Continued…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button